The pharmaceutical intermediates market in Europe is expected to grow from US$ 7,890.84 million in 2021 to US$ 10,135.51 million by 2028; it is estimated to grow at a CAGR of 3.6% from 2021 to 2028.
The UK, Germany, France, Italy, and Spain are major economies in Europe. Pharmaceutical companies are highly investing in the development of drugs and discovery of new pharmaceutical products. According to the Pharmaceutical Research and Manufacturers Association (PhRMA), pharmaceutical companies in the US conduct more than half of the world's R&D, with the investments totaling ~US$ 75 billion, and they hold intellectual property rights on most of the new pharmaceuticals. Further, a research based pharmaceutical industry is an important asset of the European economy and is one of the top-performing high-technology sectors in region. As per the EFPIA member associations, the research-based pharmaceutical industry in Europe invested around US$ 43,437.88 million (€ 36,500 million) in R&D in 2018. Such high investments in the R&D activities by the pharmaceutical companies are further driving the growth of the pharmaceutical intermediates market
Among all European countries, Spain, Italy, Germany, France, and the UK are most affected due to the increasing number of coronavirus cases and deaths associated with it. As per the Worldometer as of April, 2021, in Spain, Italy, Germany, France, and UK, the number of cases is 3,370,256; 3,779,594; 3,021,064; 5,067,216; and 4,373,343 respectively and number of deaths are also high. Various companies have undergone severe losses in the last quarter of 2019 and have negatively impacted the year 2020. As to control the spread of disease, countries have imposed complete lockdown. The lockdown has resulted in slower economies due to closed trades and business. The health and wellness market in Europe is observing steady growth due to the outbreak of coronavirus pandemic. Europeans are looking for different and natural ways of staying healthy and enhance their immune system. Lockdown and quarantine measures in Europe has led to a change in consumer buying habits. Some health categories are witnessing short-term decline in growth, while few are having positive effect on the sales of vitamins, dietary supplements, and analgesics with a strong focus on immunity and prevention. So, health supplements that were trending fine before the lockdown scenario have suddenly gained more attention as more consumers are looking for products that can help them in staying healthy. Multivitamins is one of the products that is gaining excellent popularity during pandemic. So, there is increased interest in how vitamins and health supplements can help people with their health and wellness in the coronavirus era. In France, specialist organic food shops have reported sales increases of over 40 percent. Holland & Barrett, the leading health food retailer in the UK, put a cap on supplement purchases due to its rising demand. Online retailer Healthspan reported that at end of March 2020, the sales of vitamin C supplements had tripled in a week. These factors are likely to have positive impact on the market growth.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the pharmaceutical intermediates market. The Europe pharmaceutical intermediates market is expected to grow at a good CAGR during the forecast period.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Europe Pharmaceutical Intermediates Market Segmentation
Europe Pharmaceutical Intermediates Market – By Type
- GMP
- Non GMP
Europe Pharmaceutical Intermediates Market – By Application
- Antibiotics
- Antipyretic analgesics
- Vitamins
- Others
Europe Pharmaceutical Intermediates Market – By Distribution Channel
- Distributor
- Direct Sales
Europe Pharmaceutical Intermediates Market- By Country
- Germany
- France
- Italy
- United Kingdom
- Spain
- Rest of Europe
Europe Pharmaceutical Intermediates Market-Companies Mentioned
- BASF SE
- chiracon GmbH
- Codexis
- Dextra Laboratories Limited
- Dishman Carbogen Amcis Ltd
- Midas Pharma GmbH
- Pfizer Inc.
- Sanofi
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Pharmaceutical Intermediates Market – By Type
1.3.2 Europe Pharmaceutical Intermediates Market – By Application
1.3.3 Europe Pharmaceutical Intermediates Market – By Distribution Channel
1.3.4 Europe Pharmaceutical Intermediates Market– By Country
2. Pharmaceutical Intermediates Market– Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Pharmaceutical Intermediates Market– Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Expert Opinion
5. Europe Pharmaceutical Intermediates Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Chronic Diseases and Infectious Diseases
5.1.2 Increase in R&D Investments by Pharmaceutical Companies
5.2 Market Restraints
5.2.1 High Cost of Manufacturing
5.3 Market Opportunities
5.3.1 Emerging Markets
5.4 Future Trends
5.4.1 Increasing Adoption of AI-based Tools for Drug Discovery
5.5 Impact Analysis
6. Pharmaceutical Intermediates Market– Europe Analysis
6.1 Europe Pharmaceutical Intermediates Market Revenue Forecast and Analysis
7. Europe Pharmaceutical Intermediates Market Analysis – By Type
7.1 Overview
7.2 Pharmaceutical Intermediates Market Revenue Share, by Type (2020 and 2028)
7.3 GMP
7.3.1 Overview
7.3.2 GMP: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
7.4 Non GMP
7.4.1 Overview
7.4.2 Non GMP: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
8. Europe Pharmaceutical Intermediates Market Analysis – By Application
8.1 Overview
8.2 Pharmaceutical Intermediates Market Revenue Share, by Application (2020 and 2028)
8.3 Antibiotics
8.3.1 Overview
8.3.2 Antibiotics: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
8.4 Antipyretic Analgesics
8.4.1 Overview
8.4.2 Antipyretic Analgesics: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
8.5 Vitamins
8.5.1 Overview
8.5.2 Vitamins: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
8.6 Other
8.6.1 Overview
8.6.2 Other: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
9. Europe Pharmaceutical Intermediates Market– By Distribution Channel
9.1 Overview
9.2 Pharmaceutical Intermediates Market, by Distribution Channel, 2020 and 2028 (%)
9.3 Distributor
9.3.1 Overview
9.3.2 Distributor: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
9.4 Direct Sales
9.4.1 Overview
9.4.2 Direct Sales: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
10. Europe Pharmaceutical Intermediates Market – Country Analysis
10.1.1 Overview
10.1.2 Europe: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)
10.1.3 Germany: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.1.3.1 Germany: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.1.3.2 Germany: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.1.3.3 Germany: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.1.3.4 Germany: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.4 UK: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.1.4.1 UK: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.1.4.2 UK: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.1.4.3 UK: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.1.4.4 UK: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.5 France: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.1.5.1 France: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.1.5.2 France: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.1.5.3 France: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.1.5.4 France: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.6 Spain: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.1 Spain: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2 Spain: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.1.6.3 Spain: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.1.6.4 Spain: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.7 Italy: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.1.7.1 Italy: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.1.7.2 Italy: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.1.7.3 Italy: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.1.7.4 Italy: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.8 Rest of Europe: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.1.8.1 Rest of Europe: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
10.1.8.2 Rest of Europe: Pharmaceutical Intermediates Market, by Type, 2019–2028 (USD Million)
10.1.8.3 Rest of Europe: Pharmaceutical Intermediates Market, by Application, 2019–2028 (USD Million)
10.1.8.4 Rest of Europe: Pharmaceutical Intermediates Market, by Distribution Channel, 2019–2028 (USD Million)
11. Impact of COVID-19 Pandemic on Europe Pharmaceutical Intermediates Market
11.1 Overview
12. Europe Pharmaceutical Intermediates Market– Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Pfizer Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Sanofi
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 BASF SE
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Dishman Carbogen Amcis Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Codexis
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Midas Pharma GmbH
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 chiracon GmbH
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Dextra Laboratories Limited
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe Pharmaceutical Intermediates Market Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 3. Germany Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. Germany Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 5. UK Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 6. UK Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 7. UK Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 8. France Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 9. France Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 10. France Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 11. Spain Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 12. Spain Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 13. Spain Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 14. Italy Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 15. Italy Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 16. Italy Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 17. Rest of Europe Pharmaceutical Intermediates Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of Europe Pharmaceutical Intermediates Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 19. Rest of Europe Pharmaceutical Intermediates Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 20. Organic Developments Done By Companies
Table 21. Inorganic Developments Done By Companies
Table 22. Glossary of Terms, Europe Pharmaceutical Intermediates Market
LIST OF FIGURES
Figure 1. Europe Pharmaceutical Intermediates Market Segmentation
Figure 2. Europe Pharmaceutical Intermediates Segmentation, By Country
Figure 3. Europe Pharmaceutical Intermediates Market Overview
Figure 4. GMP Held Largest Share of Type Segment in Europe Pharmaceutical Intermediates Market
Figure 5. UK to Show Remarkable Growth During Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Expert Opinion
Figure 8. Europe Pharmaceutical Intermediates Market Impact Analysis of Driver and Restraints
Figure 9. Europe Pharmaceutical Intermediates Market– Revenue Forecast and Analysis – 2019- 2028
Figure 10. Europe Pharmaceutical Intermediates Market Revenue Share, by Type (2020 and 2028)
Figure 11. Europe GMP: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
Figure 12. Europe Non GMP Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
Figure 13. Europe Pharmaceutical Intermediates Market Revenue Share, by Application (2020 and 2028)
Figure 14. Europe Antibiotics: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
Figure 15. Europe Antipyretic Analgesics: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
Figure 16. Europe Vitamins: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
Figure 17. Europe Other: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
Figure 18. Europe Pharmaceutical Intermediates Market, by Distribution Channel, 2020 and 2028 (%)
Figure 19. Europe Distributor: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
Figure 20. Europe Direct Sales: Pharmaceutical Intermediates Market– Revenue and Forecast to 2028 (US$ Million)
Figure 21. Europe: Pharmaceutical Intermediates Market, by Key Country – Revenue (2020) (USD Million)
Figure 22. Europe: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)
Figure 23. Germany: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
Figure 24. UK: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
Figure 25. France: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
Figure 26. Spain: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
Figure 27. Italy: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. Rest of Europe: Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. Impact of COVID-19 Pandemic in European Country Markets
- BASF SE
- chiracon GmbH
- Codexis
- Dextra Laboratories Limited
- Dishman Carbogen Amcis Ltd
- Midas Pharma GmbH
- Pfizer Inc.
- Sanofi
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For